Van der Heijde D, et al. Ixekizumab Significantly Improves Signs, Symptoms, and Spinal Inflammation of Active Ankylosing Spondylitis/Radiographic Axial Spondyloarthritis: 16-Week Results of a Phase 3 Randomized, Active and Placebo-Controlled Trial. ACR 2018, abstract 1864.
Cardiovasculair risico bij reumapatiënten behandeld met biologicals of tofacitinib
mrt 2018 | Arthritis psoriatica, JIA, RA, Spondyloartritis